Value-based health care is one of the most promising developments in the health industry, but the United States trails behind several developed nations in its implementation, a Boston Consulting Group (BCG) report finds.
The BCG report evaluates each of the 12 countries' health systems along two dimensions, according to report coauthor Neil Soderlund. The first dimension examines the degree to which fundamental components of a value-based health care model are in place, including:
- National legal and consent frameworks;
- Common national standards and IT infrastructure;
- The ability to tie costs with health outcomes; and
- The degree of engagement among clinicians and policymakers.
The second dimension evaluates the richness of the disease registries in each country and how well their medical communities use the data in the registries.
Findings: Sweden tops the charts, United States lags behind
The United States—which spends 17.6% of its GDP on health care and has the highest per capita costs of the 12 nations studied—is also among the countries further behind in implementing value-based health care, says report author Peter Lawyer.
Lawyer attributes the United States' lagging adoption to its fragmented health system, which limits the collection and use of health outcome data. "Reporting standards and clinical outcome metrics differ substantially across the system, even within the same specialty," he adds.
What the U.S. can learn from other developed nationsDespite the different level of progress that each nation has made on value-based health care implementation and the systems' different structures, "there is much to learn from each country," Larsson says.
- Reserve your seat for our 2012-2013 Health Care Advisory Board national meetings to hear our latest insights on transitioning your health system's business, clinical, and network model to thrive in a value-based health care economy.
For instance, the analysis indicates that the United States should champion the widespread systematic use of disease registries. "National medical societies, in particular, have a leadership role to play, both in creating uniform standards for data collection and in securing broad support and participation of practicing clinicians," says BCG's Martin Silverstein (Health Leaders Media, 10/12; BCG report, June 2012; BCG release, 6/6).